A machine learning model developed by Duke Health researchers can differentiate normal cognition from mild cognitive impairment using retinal images from the eye.
Brain imaging scans are powerful tools for diagnosing Parkinson’s disease (PD) and ruling out other motor disorders. In PD, the presence of α-synuclein (α-Syn) in…
Alzheimer’s disease (AD) is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells to die. AD is the most common…
Older adults with dementia diagnosis are as likely to be registered for a patient portal as those without dementia, and they have a lower portal…
The term “sundowning” is sometimes used to describe a tendency for people living with dementia to become more confused in the late afternoon and into…
The US drug regulator gave full approval to a new Alzheimer’s medicine on Thursday, a move that makes it more widely available to the public…
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer’s disease
Researchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzheimer’s disease (AD). In a paper, “Proteomics…
Patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment expected to soon receive approval from the U.S. Food and Drug Administration…
Older people who have fluctuating levels of cholesterol and triglycerides may have a higher risk of Alzheimer’s disease and related dementias compared to people who…
Could something as basic as a good night’s sleep protect African Americans who have a gene variant linked to Alzheimer’s Disease?